Shimose, S., Hiraoka, A., Nakano, M., Iwamoto, H., Tanaka, M., Tanaka, T., . . . Torimura, T. (2021). First‐line sorafenib sequential therapy and liver disease etiology for unresectable hepatocellular carcinoma using inverse probability weighting: A multicenter retrospective study. Wiley.
Style de citation Chicago (17e éd.)Shimose, Shigeo, et al. First‐line Sorafenib Sequential Therapy and Liver Disease Etiology for Unresectable Hepatocellular Carcinoma Using Inverse Probability Weighting: A Multicenter Retrospective Study. Wiley, 2021.
Style de citation MLA (8e éd.)Shimose, Shigeo, et al. First‐line Sorafenib Sequential Therapy and Liver Disease Etiology for Unresectable Hepatocellular Carcinoma Using Inverse Probability Weighting: A Multicenter Retrospective Study. Wiley, 2021.